ΠΑΠΙΜΙ
May 2008
Athlete suffering from chondropathia after being treated with PAPIMI device
plus chondroitine and glucozamine wins the Copper Medal !
by Dr. Nick Papandreou M.D.
Female athlete
A.S 38 years old came in my practice a wile ago diagnosed as suffering from
chondropathia of the knee
Patient was exposed in the pulsed magnetic field of the PAPIMI device around two or three times per week, for 30 minutes each time for one year. During this treatment she received also chondroitine and glucozamine as food supplements.
The results were outstanding, since in the athletic event "Olympus Marathon 2007" she won the Copper Medal !
----------------------------------------------------------------------------------------------------------------------------------
May 2008
Application of PAPIMI device and antioxidants to primary hepatoma
by Dr. Nick Papandreou MD.
A 88 years old male patient came to my practice about one and a half year ago diagnosed with primary hepatoma. From then on, he has been exposed to the pulsed magnetic field of PAPIMI device three times per week, for 30 minutes each time and at the same time he was taking vitamins and antioxidants as food supplements.
Here follows a partial record of the observed findings :
|
Date
|
Examination |
Findings |
|
|
|
|
|
08/08/2006 |
Calculating Tomography |
Liver tissue formation 8cm diameter |
|
|
|
|
|
|
|
|
|
22/09/2006 |
A-Fetoprotein (AFP) |
60500,0 ng / ml (reference values: 0,0 – 15,0) |
|
|
|
|
|
|
|
|
|
07/11/2006 |
A-Fetoprotein (a-FP) |
39,5 μg / ml (reference values : < 10 ng/ml) |
|
07/11/2006 |
Liver Ultrasonogram |
Liver tissue formation 7,9 cm diameter |
|
|
|
|
|
|
|
|
|
06/02/2007 |
Triplex |
Liver tissue formation diameter 52,8 mm |
|
06/02/2007 |
A-Fetoprotein (a-FP) |
364,8 (reference values : < 7,0 ng/ml) |
|
|
|
|
|
07/02/2007 |
Liver Ultrasonic Control 4D |
Liver tissue formation 3,9 X 3,2 cm diameter |
|
|
|
|
|
|
|
|
|
09/05/2007 |
Liver Ultrasonic Control 4D |
Liver tissue formation diameter 21,8 mm |
|
09/05/2007 |
A - FP |
22,45 ng / ml (reference values: < 10) |
|
09/05/2007 |
CA 19-9 |
9,16 IU / ml (reference values: < 39,0 ) |
|
09/05/2007 |
C.E.A |
2,77 ng / ml (reference values: < 5) |
|
|
|
|
|
|
|
|
|
18/7/2007 |
A-Fetoprotein (AFP) |
10,9 ng / ml (reference values: 0,0 – 15,0) |
|
18/7/2007 |
CA 19-9 |
6,6 IU / ml (reference values < 39,0 ) |
|
18/7/2007 |
CEA |
2,2 ng / ml (reference values 0,0 – 5,0 ) |
|
18/7/2007 |
Calculating Tomography |
Liver tissue formation 3 cm maximum diameter |
|
|
|
|
|
|
|
|
|
10/10/2007 |
AFP |
18,4 ng / ml (reference values: 0 - 8,1) |
|
10/10/2007 |
CA 19.9 |
4,9 U / ml (reference values: 0 - 37 ) |
|
10/10/2007 |
CEA |
1,32 ng / ml (reference values: < 5 ) |
|
|
|
|
|
12/10/2007 |
Ultrasonic Control 4D |
Liver tissue formation 2,9 mm maximum diameter and volume 9,4 ml |
|
|
|
|
|
|
|
|
|
16/11/2007 |
Ultrasonogram of the upper abdomen |
Liver tissue formation 4,75 X 2,19 cm |
|
|
|
|
|
|
|
|
|
02/01/2008 |
Calculating Tomography |
Liver tissue formation 20 mm maximum diameter |
|
|
|
|
|
07/01/2008 |
Ultrasonic Control 4D |
Liver tissue formation of maximum diameter 2,9 mm and volume 9,4 ml |
|
07/01/2008 |
NF – kB |
3,144 ( reference value < 18,368) |
|
|
|
|
|
|
|
|
|
16/01/2008 |
AFP |
54,2 ng / ml (reference values: 0 - 8,1) |
|
16/01/2008 |
CA 19.9 |
4,1 U / ml (reference values: 0 - 37 ) |
|
16/01/2008 |
CEA |
1,06 ng / ml (reference values: < 5) |
|
|
|
|
|
23/01/2008 |
A-Fetoprotein (AFP) |
56,0 ng / ml (reference values: 0,0 – 15,0) |
|
|
|
|
Comments :
Liver tissue formation - as measured by calculating tomography - has been
reduced from a 8 cm diameter to a 2 cm maximum diameter within 17 months,
that is from August 2006 to January 2008.
A - Fetoprotein
has been reduced from 60500,0 ng/ml to
56,0 ng/ml within
16 months, that is from September 2006 to January 2008